Becton, Dickinson and Company (NYSE:BDX) Releases FY 2025 Earnings Guidance

Key Points

• Becton, Dickinson and Company issued FY 2025 earnings guidance with EPS expected between $14.300 and $14.450, exceeding the consensus estimate of $14.183.
• The company's revenue guidance ranges from $21.8 billion to $21.9 billion, aligned with the consensus estimate of $21.8 billion.
• Becton, Dickinson announced a quarterly dividend of $1.04 per share, representing an annual yield of 2.4%, with a payout ratio of 79.39%.

Becton, Dickinson and Company (NYSE:BDX - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 14.300-14.450 for the period, compared to the consensus estimate of 14.183. The company issued revenue guidance of $21.8 billion-$21.9 billion, compared to the consensus revenue estimate of $21.8 billion.

Becton, Dickinson and Company Trading Down 2.5%

Shares of BDX stock opened at $172.50 on Thursday. The stock has a market capitalization of $49.44 billion, a P/E ratio of 32.92, a price-to-earnings-growth ratio of 1.34 and a beta of 0.20. Becton, Dickinson and Company has a fifty-two week low of $163.33 and a fifty-two week high of $251.99. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.64 and a current ratio of 1.13. The company has a 50 day moving average price of $175.11 and a 200 day moving average price of $199.64.

Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $3.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.44 by $0.24. Becton, Dickinson and Company had a return on equity of 15.99% and a net margin of 7.28%. Equities research analysts predict that Becton, Dickinson and Company will post 14.43 EPS for the current fiscal year.

Becton, Dickinson and Company Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Monday, September 8th will be issued a dividend of $1.04 per share. This represents a $4.16 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend is Monday, September 8th. Becton, Dickinson and Company's payout ratio is 79.39%.

Analysts Set New Price Targets

BDX has been the topic of a number of recent analyst reports. Morgan Stanley dropped their price objective on Becton, Dickinson and Company from $280.00 to $196.00 and set an "overweight" rating on the stock in a report on Tuesday, May 6th. Stifel Nicolaus dropped their target price on shares of Becton, Dickinson and Company from $280.00 to $224.00 and set a "buy" rating on the stock in a research report on Friday, May 2nd. Citigroup cut shares of Becton, Dickinson and Company from a "strong-buy" rating to a "hold" rating and reduced their price target for the company from $217.00 to $185.00 in a research report on Thursday, May 22nd. Wall Street Zen cut Becton, Dickinson and Company from a "buy" rating to a "hold" rating in a research report on Friday, May 2nd. Finally, Raymond James Financial downgraded Becton, Dickinson and Company from an "outperform" rating to a "market perform" rating in a research note on Friday, May 2nd. Eight analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $212.88.

Insider Buying and Selling at Becton, Dickinson and Company

In other news, EVP David Shan sold 1,166 shares of the firm's stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $171.19, for a total value of $199,607.54. Following the completion of the sale, the executive vice president owned 4,575 shares in the company, valued at approximately $783,194.25. This trade represents a 20.31% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael David Garrison sold 1,185 shares of the stock in a transaction dated Friday, July 18th. The stock was sold at an average price of $180.29, for a total transaction of $213,643.65. Following the transaction, the executive vice president directly owned 4,887 shares of the company's stock, valued at $881,077.23. This represents a 19.52% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.36% of the stock is owned by company insiders.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Becton, Dickinson and Company stock. Brighton Jones LLC grew its holdings in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 98.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,770 shares of the medical instruments supplier's stock after purchasing an additional 877 shares during the quarter. Brighton Jones LLC's holdings in Becton, Dickinson and Company were worth $401,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 86.97% of the company's stock.

Becton, Dickinson and Company Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.